心血管設備市場規模、佔有率、成長分析、按產品、按應用、按最終用戶、按地區 - 行業預測，2024-2031 年

2022年全球心血管器材市場規模估值為449億美元，從2023年的491億美元成長到2031年的949億美元，預測期內（2024-2031年）年複合成長率為8.5，預計將成長8.5%。

在慢性心血管疾病盛行率上升的推動下，全球心血管設備市場正經歷強勁成長。哈佛大學陳曾熙公共衛生學院的一項研究指出，印度馬哈拉斯特拉邦拉邦的心臟麻痹增加了 43%，這歸因於冠狀動脈支架成本的下降。心臟關鍵藥物（尤其是冠狀動脈繞道手術療法）價格的下降進一步支持了市場擴張，特別是在印度等新興經濟體。主要成長動力包括快速的技術進步、全球心血管疾病負擔的增加以及向微創治療方法的轉變。此外，心臟設備製造的創新擴大了適應症並改善了患者管理，使心律調節器等設備在全球心臟病的有效診斷和治療中發揮重要作用已變得顯而易見。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 抑制因素和挑戰
• 波特分析及影響
  • 競爭公司之間的敵對關係
  • 替代品的威脅
  • 買方議價能力
  • 新進入者的威脅
  • 供應商的議價能力

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 技術進步
• 監管環境
• 專利分析
• 價值鏈分析
• PESTEL分析
• 總體經濟指標
• 市場吸引力指數

心血管設備市場規模：依產品及年複合成長率（2024-2031）

• 市場概況
• 診斷和監測設備
  • 心電圖
  • 植入式心臟監測儀
  • 心電圖監測
  • 移動心電遙測
  • MRI
  • 心血管超音波檢查
  • 2D
  • 3D/4D
  • 多普勒
  • 心臟診斷導管
  • 正子斷層掃描儀
• 手術設備
  • 心臟再同步治療（CRT）
  • CRT心臟去顫器
  • CRT心律調節器
  • 植入式心臟整流去顫器(ICD)
  • 單腔ICD
  • 雙腔室ICD
  • 心律調節器
  • 傳統心律調節器
  • 無導線心律調節器
  • 冠狀動脈支架
  • 導管
  • 導管導引線
  • 插管
  • 閥門
  • 阻塞設備

心血管設備市場規模：依應用與年複合成長率（2024-2031）

• 市場概況
• 冠狀動脈疾病（CAD）
• 心律不整
• 心臟衰竭
• 其他

心血管設備市場規模：依最終用戶和年複合成長率（2024-2031）

• 市場概況
• 醫院
• 專科診所
• 其他

心血管設備市場規模及年複合成長率（2024-2031）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• Abbott Laboratories
• Boston Scientific Corporation
• Medtronic, Inc.
• Johnson & Johnson
• Terumo Corporation
• Edwards Lifesciences Corporation
• Biotronik SE & Co. KG
• LivaNova PLC
• Getinge AB
• Baxter International Inc.（Hill-Rom Holdings, Inc.）
• Koninklijke Philips NV
• Siemens Healthineers AG
• GE Healthcare
• Toshiba Corporation
• Fujifilm Holdings Corporation
• Hitachi, Ltd.
• Nihon Kohden Corporation
• Collateral Medical Pvt. Ltd.
• Schiller AG
• B. Braun Melsungen AG

結論和建議

Global Cardiovascular Devices Market size was valued at USD 44.9 billion in 2022 and is poised to grow from USD 49.1 billion in 2023 to USD 94.9 billion by 2031, growing at a CAGR of 8.5% during the forecast period (2024-2031).

The global cardiovascular device market is experiencing robust growth, driven by the rising incidence of chronic cardiovascular diseases. A study from Harvard's T.H. Chan School of Public Health highlights a 43% surge in cardiac arrests in Maharashtra, India, attributed to the reduced costs of coronary stents. The decline in essential cardiac drug prices, notably coronary artery bypass therapy, is further propelling market expansion, particularly in emerging economies like India. Key growth drivers include rapid technological advancements, a rising global burden of cardiovascular conditions, and a shift towards less invasive treatment options. Additionally, innovation in cardiac device manufacturing has broadened indications and improved patient management, underscoring the vital role of devices like pacemakers in effectively diagnosing and treating heart diseases globally.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiovascular Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiovascular Devices Market Segmental Analysis

Global Cardiovascular Devices Market is segmented by product, application, end user and region. Based on product, the market is segmented into Diagnostic & Monitoring Devices (ECG, Implantable Cardiac Monitors, Holter Monitors, Mobile Cardiac Telemetry, MRI, Cardiovascular Ultrasound (2D, 3D/4D, Doppler), Cardiac Diagnostic Catheters, PET Scanner), Surgical Devices (Cardiac Resynchronization Therapy (CRT) (CRT-Defibrillator, CRT-Pacemaker), Implantable Cardioverter Defibrillators (ICDs) (Single Chamber ICDs, Dual Chamber ICDs), Pacemakers (Conventional Pacemakers, Leadless Pacemakers), Coronary Stents, Catheters, Guidewires, Cannula, Valves, Occlusion Devices). Based on application, the market is segmented into Coronary Artery Disease (CAD), Cardiac Arrhythmia, Heart Failure and Others. Based on end user, the market is segmented into Hospitals, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiovascular Devices Market

The Global Cardiovascular Devices market is significantly influenced by the escalating incidence of cardiovascular diseases (CVDs), which remain the foremost cause of mortality worldwide. The rising prevalence of sedentary lifestyles, unhealthy diets, and an aging demographic contributes to an increased risk of conditions like congestive heart failure, hypertension, and heart failure. As a result, there is a growing necessity for vital medical devices, including pacemakers, defibrillators, and stents, particularly in both developed and developing regions. Health systems are now focusing on preventive care and early disease detection, while hospitals and clinics adopt advanced technologies to enhance patient outcomes. Furthermore, government initiatives and nonprofit organizations are actively promoting awareness among high-risk populations, further driving the market's growth.

Restraints in the Global Cardiovascular Devices Market

One significant constraint faced by the global cardiovascular devices market is the high cost associated with advanced equipment. This challenge is particularly pronounced in developing regions where the affordability of advanced devices, such as implantable cardioverter defibrillators (ICDs) and sophisticated imaging technologies, proves to be a substantial hurdle. The hefty price tags attached to these devices can deter healthcare providers and patients alike, limiting their availability and accessibility. Furthermore, inadequate insurance coverage and reimbursement options in certain areas exacerbate this issue, leaving patients without access to potentially life-saving technologies, ultimately hindering the growth and adoption of cardiovascular interventions.

Market Trends of the Global Cardiovascular Devices Market

The Global Cardiovascular Devices market is experiencing a significant shift towards expanding home health solutions, driven by the increasing demand for self-management tools and remote patient monitoring technologies. Wearable ECG devices, blood pressure monitors, and other innovative remote monitoring solutions enable patients to capture real-time health data, empowering them to manage chronic conditions like heart failure more effectively from the comfort of their homes. This trend not only improves patient convenience and engagement but also reduces healthcare costs and enhances the focus on preventive care. As patients seek greater autonomy in managing their health, the market is poised for sustained growth and innovation.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Value Chain Analysis
• PESTEL Analysis
• Macro-Economic Indicators
• Market Attractiveness Index

Global Cardiovascular Devices Market Size by Product & CAGR (2024-2031)

• Market Overview
• Diagnostic & Monitoring Devices
  • ECG
  • Implantable Cardiac Monitors
  • Holter Monitors
  • Mobile Cardiac Telemetry
  • MRI
  • Cardiovascular Ultrasound
  • 2D
  • 3D/4D
  • Doppler
  • Cardiac Diagnostic Catheters
  • PET Scanner
• Surgical Devices
  • Cardiac Resynchronization Therapy (CRT)
  • CRT-Defibrillator
  • CRT-Pacemaker
  • Implantable Cardioverter Defibrillators (ICDs)
  • Single Chamber ICDs
  • Dual Chamber ICDs
  • Pacemakers
  • Conventional Pacemakers
  • Leadless Pacemakers
  • Coronary Stents
  • Catheters
  • Guidewires
  • Cannula
  • Valves
  • Occlusion Devices

Global Cardiovascular Devices Market Size by Application & CAGR (2024-2031)

• Market Overview
• Coronary Artery Disease (CAD)
• Cardiac Arrhythmia
• Heart Failure
• Others

Global Cardiovascular Devices Market Size by End User & CAGR (2024-2031)

• Market Overview
• Hospitals
• Specialty Clinics
• Others

Global Cardiovascular Devices Market Size & CAGR (2024-2031)

• North America (Product, Application, End User)
  • US
  • Canada
• Europe (Product, Application, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Product, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Product, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (Hill-Rom Holdings, Inc.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Toshiba Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hitachi, Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Collateral Medical Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schiller AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation